Asianet Newsable on MSN
Theriva™ Biologics licenses SYN-020 to Rasayana Therapeutics for multiple indications
Theriva received a $300,000 upfront payment at signing and is eligible for up to $38M in development, regulatory, and sales ...
The spray-mist device developed by the researchers can reportedly deliver last-resort antibiotics directly into infected tissue without incurring the harmful side effects typically caused by ...
I am 78 years old and in fair health.
ROACH: About one year ago, I had Clostridioides difficile (C. diff) that was treated with 125 mg of vancomycin for about four weeks. I had none of the usual risk factors, and the cause was never ...
A new review finds that women receive 25%-40% more antibiotics, experience up to twice as many adverse reactions, yet are underrepresented in trials; clinicians should adopt sex-aware prescribing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results